Related Experiment Video
Updated: Sep 15, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
Neuropathogenicity of group A Coxsackie viruses
Abstract:
Coxsackie virus, Group A, Type 14, has been adapted to adult mice and monkeys and induces in them poliomyelitis-like lesions and, in the case of the mice, flaccid paralysis.
Insights
Coxsackie virus A14 adapted to adult mice and monkeys causes poliomyelitis-like symptoms. Infected mice developed flaccid paralysis, indicating significant neurological impact.
Area of Science:
- Virology
- Neurology
- Pathology
Background:
- Coxsackie viruses are known human enteroviruses.
- Previous research has focused on other strains' neurotropic potential.
Purpose of the Study:
- To investigate the pathogenicity of Coxsackie virus, Group A, Type 14 (CAV-14) in adult animal models.
- To determine if CAV-14 can induce neurological disease similar to poliomyelitis.
Main Methods:
- Adaptation of CAV-14 to adult mice and monkeys.
- Observation and documentation of clinical signs and pathological lesions.
Main Results:
- CAV-14 successfully adapted to both adult mice and monkeys.
- Both species exhibited poliomyelitis-like lesions.
- Adult mice specifically developed flaccid paralysis.
Conclusions:
- CAV-14 demonstrates neurovirulence in adult mice and monkeys.
- The virus can induce paralytic disease, highlighting its potential as a model for poliomyelitis research.
Related Concept Videos
Arboviral Encephalitis
Encephalitis ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Cytomegalovirus Disease
Poliomyelitis

